Discover / Filter / Explore

Stock screener

Find the businesses that fit your questions.

Each company's latest annual period, from SEC filings. Monetary filters use the selected currency; amounts are never converted. Companies with no annual report in the last 18 months are left out unless you include them.

463 companies

Ticker	Company	Revenue	Net income ▾	Net margin	Return on equity	Revenue growth	Diluted EPS
ZBIO	Zenas BioPharma, Inc. Manufacturing · Year ended 2025-12-31 · USD	$10.00M	-$377.74M	n/m	-156.0%	100.0%	-$8.44
IONS	Ionis Pharmaceuticals Inc Manufacturing · Year ended 2025-12-31 · USD	$943.71M	-$381.39M	-40.4%	-78.0%	33.8%	-$2.38
AGIO	Agios Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$54.03M	-$412.78M	-764.0%	-34.6%	48.0%	-$7.12
DYN	Dyne Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$446.21M	n/a	-45.9%	n/a	-$3.47
RARE	Ultragenyx Pharmaceutical Inc. Manufacturing · Year ended 2025-12-31 · USD	$673.00M	-$575.00M	-85.4%	n/a	20.2%	-$5.83
SRPT	Sarepta Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$2.20B	-$713.41M	-32.5%	-62.5%	15.6%	-$7.13
BBIO	BridgeBio Pharma, Inc. Manufacturing · Year ended 2025-12-31 · USD	$502.08M	-$732.94M	-146.0%	n/a	126.3%	-$3.78
BHVN	Biohaven Ltd. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$738.82M	n/a	n/m	n/a	-$6.86
CYTK	Cytokinetics Inc Manufacturing · Year ended 2025-12-31 · USD	$88.04M	-$784.96M	-891.6%	n/a	376.6%	-$6.54
SMMT	Summit Therapeutics Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$1.08B	n/a	-163.9%	n/a	-$1.44
INSM	Insmed Inc Manufacturing · Year ended 2025-12-31 · USD	$606.42M	-$1.28B	-210.5%	-172.8%	66.7%	-$6.42
PRGO	Perrigo Co PLC Manufacturing · Year ended 2025-12-31 · USD	$4.25B	-$1.43B	-33.5%	-48.6%	-2.8%	-$10.29
VTRS	Viatris Inc Manufacturing · Year ended 2025-12-31 · USD	$14.30B	-$3.51B	-24.6%	-23.9%	-3.0%	-$3.00

Rows per page: 2550 100